U.S. markets closed

What AstraZeneca's $1B funding for Oxford's coronavirus vaccine means for the U.S.

Pharmaceutical company AstraZeneca secures $1.2 billon to produce the University of Oxford’s COVID-19 vaccine. Yahoo Finance’s Anjalee Khemlani breaks down the latest developments.